Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.585
+0.025 (0.98%)
Aug 27, 2026, 4:08 PM HKT

Hua Medicine (Shanghai) Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,0731,0921,1401,461490.63675.24
Cash & Short-Term Investments
1,0731,0921,1401,461490.63675.24
Cash Growth
4.90%-4.16%-21.98%197.74%-27.34%-34.58%
Accounts Receivable
158.3274.8334.390.9812.94-
Other Receivables
-4.7822.1815.81408.969.7
Receivables
158.3279.6156.5716.79421.99.7
Inventory
116.2121.85126.767.8718.46-
Prepaid Expenses
-1.45----
Other Current Assets
-1.2413.48279.2719.66
Total Current Assets
1,3471,2961,3361,572940.26704.6
Property, Plant & Equipment
103.05110.07129.66114.54139.71156.6
Other Intangible Assets
22.4222.5926.0728.5731.959.03
Other Long-Term Assets
42.1340.6535.079.799.5833.33
Total Assets
1,5151,4701,5271,7251,121903.55

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
168.1281.6563.7251.6320.9823.79
Accrued Expenses
-60.3837.937.1738.3732.15
Short-Term Debt
215.98---33.92-
Current Portion of Long-Term Debt
-30.6198.2817.19--
Current Portion of Leases
19.1218.0517.2624.2821.4913.3
Current Unearned Revenue
--98.0498.3853.8613.85
Other Current Liabilities
-19.5815.0723.3819.7623.8
Total Current Liabilities
403.22210.27330.27252.03188.39106.88
Long-Term Debt
97.33220.56138.74106.84--
Long-Term Leases
21.8432.4645.9119.4442.1758.23
Long-Term Unearned Revenue
--1,1481,246611.36288.11
Total Liabilities
522.38463.281,6631,624841.92453.22

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
7.227.227.217.217.217.21
Additional Paid-In Capital
-5,9555,9325,9315,9225,910
Retained Earnings
--5,255-6,361-6,111-5,900-5,696
Treasury Stock
-0.4-0.41-0.49-0.51-0.58-0.63
Comprehensive Income & Other
985.86299.01286.43274.5250.96229.63
Total Common Equity
992.681,006-135.47101.15279.58450.33
Shareholders' Equity
992.681,006-135.47101.15279.58450.33
Total Liabilities & Equity
1,5151,4701,5271,7251,121903.55

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
354.26301.67300.18167.7597.5871.53
Net Cash (Debt)
718.68790.62839.571,293393.05603.71
Net Cash Growth
-4.40%-5.83%-35.07%228.98%-34.89%-36.54%
Net Cash Per Share
0.720.790.861.320.410.63
Filing Date Shares Outstanding
1,007996.52983.66980.52970.11963.55
Total Common Shares Outstanding
1,007996.52983.66980.52970.11963.55
Working Capital
944.241,0861,0061,320751.87597.72
Book Value Per Share
0.991.01-0.140.100.290.47
Tangible Book Value
970.26983.86-161.5372.58247.63441.31
Tangible Book Value Per Share
0.960.99-0.160.070.260.46
Machinery
-28.7627.3325.4923.4621.61
Construction In Progress
-25.1424.5422.421.318.92
Leasehold Improvements
-44.3344.1543.8843.3340.06